Healthways Upgraded by Zacks to “Outperform” (HWAY)
Healthways (NASDAQ:HWAY) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a report released on Wednesday. The firm currently has a $21.00 price objective on the stock. Zacks‘s target price would suggest a potential upside of 18.04% from the stock’s previous close.
Zacks’ analyst wrote, “Healthways considers itself a global well-being company though overseas contract wins. We have upgraded our recommendation on the company to Outperform from Neutral following its turnaround 2014-second quarter, where it posted earnings per share of a penny and beat the Zacks Consensus Estimate. The company’s revenues of $180.6 million also grew 11.3% and surpassed the mark. For 2014, Healthways expects to report earnings of $0.11 to $0.26 and revenues to increase 10-15% year-over-year to $730 to $760 million. The company is making consistent progress with four large contracts scheduled for renewal in 2014. Our target is $21.00 on the stock.”
In other Healthways news, major shareholder North Tide Capital, Llc sold 100,000 shares of Healthways stock on the open market in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $17.29, for a total transaction of $1,729,000.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Several other analysts have also recently commented on the stock. Analysts at Dougherty & Co upgraded shares of Healthways from a “neutral” rating to a “buy” rating in a research note on Thursday, July 24th. Analysts at Noble Financial reiterated a “positive” rating on shares of Healthways in a research note on Thursday, June 19th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $17.00.
Shares of Healthways (NASDAQ:HWAY) remained flat at $17.79 during during mid-day trading trading on Wednesday. 89,688 shares of the company’s stock traded hands. Healthways has a one year low of $9.59 and a one year high of $22.20. The stock has a 50-day moving average of $16.89 and a 200-day moving average of $16.45. The company’s market cap is $628.6 million.
Healthways (NASDAQ:HWAY) last released its earnings data on Wednesday, July 23rd. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $180.60 million for the quarter, compared to the consensus estimate of $179.53 million. During the same quarter in the previous year, the company posted ($0.03) earnings per share. The company’s revenue for the quarter was up 11.3% on a year-over-year basis. On average, analysts predict that Healthways will post $0.21 earnings per share for the current fiscal year.
Healthways, Inc provides solutions to help people improve physical, emotional and social well-being. The Company provides specific and personalized interventions for each individual in a population, irrespective of health status, age or payor.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.